Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-10,625
Closed -$97K 1887
2025
Q1
$97K Buy
+10,625
New +$66.7K 0.01% 924
2024
Q4
Sell
-920
Closed -$9K 1909
2024
Q3
$9K Buy
920
+223
+32% +$3.25K ﹤0.01% 1212
2024
Q2
$11K Buy
+697
New +$11.7K ﹤0.01% 1120
2023
Q3
Sell
-2,197
Closed -$41K 1720
2023
Q2
$41K Buy
+2,197
New +$52K ﹤0.01% 1168
2021
Q3
Sell
-1,179
Closed -$55K 1828
2021
Q2
$55K Buy
+1,179
New +$60.2K 0.01% 1324
2021
Q1
Sell
-3,862
Closed -$240K 1904
2020
Q4
$240K Buy
+3,862
New +$237K 0.03% 760
2018
Q1
Sell
-1,500
Closed -$425K 2407
2017
Q4
$425K Buy
+1,500
New +$422K 0.02% 964

Virtu Financial's OPTN Position: Q2 2025 in Review

Virtu Financial sold out of OptiNose (OPTN) in Q2 2025, closing a stake of 10,625 shares — an estimated $97K sold.

Virtu Financial first reported a position in OPTN in Q4 2017 and held it in 7 quarters. The position peaked at $425K in Q4 2017. 0 funds tracked by Wall St. Rank hold OPTN as of Q2 2025.

  • Virtu Financial reported no remaining OptiNose position as of Q2 2025 after selling out during the quarter.
  • Virtu Financial sold 10,625 OptiNose shares in Q2 2025, an estimated $97K.
  • Virtu Financial first reported a position in OptiNose in Q4 2017 and held it in 7 quarters.
  • Virtu Financial's OptiNose position peaked at $425K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held OptiNose as of Q2 2025.

Based on Virtu Financial's 13F filing for Q2 2025, filed 12 Aug 2025.